Venkata Lakshmana R. Chunduru
Directeur/Bestuurslid bij LAURUS LABS LIMITED
Vermogen: 68 M $ op 31-05-2024
Profiel
Venkata Lakshmana R.
Chunduru is currently an Executive Director at Laurus Labs Ltd.
and a Director at Sriam Labs Pvt Ltd.
He graduated and earned a doctorate degree from Andhra University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LAURUS LABS LTD.
2.50% | 30-09-2023 | 13 450 145 ( 2.50% ) | 68 M $ | 31-05-2024 |
Actieve functies van Venkata Lakshmana R. Chunduru
| Bedrijven | Functie | Begin |
|---|---|---|
| LAURUS LABS LIMITED | Directeur/Bestuurslid | 08-03-2018 |
Sriam Labs Pvt Ltd.
 Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Directeur/Bestuurslid | 25-07-2014 |
Opleiding van Venkata Lakshmana R. Chunduru
| Andhra University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LAURUS LABS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sriam Labs Pvt Ltd.
Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Health Technology |
